JP2004532885A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004532885A5 JP2004532885A5 JP2003501497A JP2003501497A JP2004532885A5 JP 2004532885 A5 JP2004532885 A5 JP 2004532885A5 JP 2003501497 A JP2003501497 A JP 2003501497A JP 2003501497 A JP2003501497 A JP 2003501497A JP 2004532885 A5 JP2004532885 A5 JP 2004532885A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- mammal
- eye
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 241000124008 Mammalia Species 0.000 claims 3
- 102000008070 Interferon-gamma Human genes 0.000 claims 2
- 108010074328 Interferon-gamma Proteins 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 229940044627 gamma-interferon Drugs 0.000 claims 1
- 229960003130 interferon gamma Drugs 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29589501P | 2001-06-05 | 2001-06-05 | |
| US09/894,287 US6534059B2 (en) | 2001-06-05 | 2001-06-28 | Compositions and methods for treating hyperimmune response in the eye |
| PCT/US2002/017677 WO2002098460A1 (en) | 2001-06-05 | 2002-06-04 | Compositions and methods for treating hyperimmune response in the eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004532885A JP2004532885A (ja) | 2004-10-28 |
| JP2004532885A5 true JP2004532885A5 (https=) | 2006-01-05 |
Family
ID=26969391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003501497A Pending JP2004532885A (ja) | 2001-06-05 | 2002-06-04 | 眼内の過免疫応答を処置するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6534059B2 (https=) |
| EP (1) | EP1401496B1 (https=) |
| JP (1) | JP2004532885A (https=) |
| AT (1) | ATE343398T1 (https=) |
| AU (1) | AU2002318175B2 (https=) |
| CA (1) | CA2449488C (https=) |
| DE (1) | DE60215649D1 (https=) |
| WO (1) | WO2002098460A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6709655B2 (en) | 2001-02-28 | 2004-03-23 | Instituto Bioclon, S.A. De C.V. | Pharmaceutical composition of F(ab1)2 antibody fragments and a process for the preparation thereof |
| US6534059B2 (en) * | 2001-06-05 | 2003-03-18 | Advanced Biotherapy, Inc. | Compositions and methods for treating hyperimmune response in the eye |
| US6861056B2 (en) * | 2001-06-05 | 2005-03-01 | Advanced Biotherapy, Inc. | Compositions and methods for treating hyperimmune response in the eye |
| US6712976B2 (en) * | 2001-09-13 | 2004-03-30 | Abtech Industries, Inc. | Dual-action decontamination system |
| US7335759B2 (en) | 2002-12-02 | 2008-02-26 | Universidad Nacional Autónoma de Méxica (UNAM) | Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides |
| US20060210563A1 (en) * | 2003-07-25 | 2006-09-21 | Juan Lopez De Silanes | Administration of anti-cytokine f(ab')2 antibody fragments |
| MX2007008719A (es) * | 2005-01-27 | 2007-09-11 | Novimmune Sa | Anticuerpos anti-interferon gamma y metodos de uso de los mismos. |
| US20100003264A1 (en) * | 2005-03-24 | 2010-01-07 | Washington University | Reduction of Ophthalmalogic Neovascularization |
| US7381802B2 (en) * | 2005-04-15 | 2008-06-03 | Universidad Nacional Autónoma De México (UNAM) | Human antibodies that specifically recognize the toxin Cn2 from Centruroides noxius scorpion venom |
| JP2009539977A (ja) * | 2006-06-12 | 2009-11-19 | セラカイン・リミテッド | 眼表面の疾患の局所療法 |
| EP2326342B1 (en) | 2008-08-15 | 2021-10-06 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for using interferon gamma to absorb fluid from the subretinal space |
| CN121588213A (zh) | 2015-05-07 | 2026-03-03 | 瑞典孤儿比奥维特鲁姆股份公司 | 用于诊断和治疗cxcl9和其它生物标志物水平升高的患者的病症 |
| US11091543B2 (en) | 2015-05-07 | 2021-08-17 | Swedish Orphan Biovitrum Ag | Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| AU6543286A (en) | 1985-10-25 | 1987-05-19 | Zymogenetics Inc. | Method of using bar1 for secreting foreign proteins |
| JPS63501765A (ja) | 1985-11-01 | 1988-07-21 | インタ−ナショナル、ジェネティック、エンジニアリング インコ−ポレ−テッド | 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途 |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8905400D0 (en) * | 1989-03-09 | 1989-04-19 | Jonker Margreet | Medicaments |
| JP3679112B2 (ja) * | 1991-10-04 | 2005-08-03 | アメリカ合衆国 | 細胞接着分子の遮断による眼の炎症の治療 |
| US5888511A (en) | 1993-02-26 | 1999-03-30 | Advanced Biotherapy Concepts, Inc. | Treatment of autoimmune diseases, including AIDS |
| DE19535073C1 (de) * | 1995-09-21 | 1997-02-20 | Roland Dr Grosmann | Verfahren zur künstlichen Inkubation von Hühnereiern |
| US6534059B2 (en) * | 2001-06-05 | 2003-03-18 | Advanced Biotherapy, Inc. | Compositions and methods for treating hyperimmune response in the eye |
| US6861056B2 (en) * | 2001-06-05 | 2005-03-01 | Advanced Biotherapy, Inc. | Compositions and methods for treating hyperimmune response in the eye |
-
2001
- 2001-06-28 US US09/894,287 patent/US6534059B2/en not_active Expired - Fee Related
-
2002
- 2002-06-04 WO PCT/US2002/017677 patent/WO2002098460A1/en not_active Ceased
- 2002-06-04 DE DE60215649T patent/DE60215649D1/de not_active Expired - Lifetime
- 2002-06-04 JP JP2003501497A patent/JP2004532885A/ja active Pending
- 2002-06-04 CA CA2449488A patent/CA2449488C/en not_active Expired - Fee Related
- 2002-06-04 AT AT02747880T patent/ATE343398T1/de not_active IP Right Cessation
- 2002-06-04 EP EP02747880A patent/EP1401496B1/en not_active Expired - Lifetime
- 2002-06-04 AU AU2002318175A patent/AU2002318175B2/en not_active Ceased
-
2003
- 2003-02-21 US US10/372,644 patent/US7232568B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004532885A5 (https=) | ||
| JP2009507838A5 (https=) | ||
| WO2009039992A3 (en) | Use of band 3 protein (824-829) and/or melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection | |
| EA200700083A1 (ru) | Антитела, направленные против бета-амилоидного пептида, и способы их применения | |
| ZA200609407B (en) | Monoclonal antibodies to hepatocyte growth factor | |
| JP2005525352A5 (https=) | ||
| RU2015110635A (ru) | Лечение сосудистого заболевания и его осложнений | |
| CA2449488A1 (en) | Compositions and methods for treating hyperimmune response in the eye | |
| RU2342106C1 (ru) | Способ коррекции лагофтальма с выворотом нижнего века при хроническом параличе лицевого нерва | |
| DE69425246D1 (de) | Monoklonale antikoerper gegen lfa-1 zur herstellung eines arzneimittels zur vorbeugung der transplantatabstossung von organen | |
| WO2004106378A3 (en) | Method of treating corneal transplant rejection by using vegf antagonists | |
| SE9704644D0 (sv) | New use | |
| RU2002115406A (ru) | Соединение, обладающее свойствами высвобождения гормона роста | |
| RU2013137645A (ru) | Аналоги цистамина, применяемые для лечения болезни паркинсона | |
| DE60313356D1 (de) | Verwendungvon dextransulfat zur behandlung von ibmir | |
| NO20055187L (no) | Fremgangsmate for behandling og forebygging av lavere urinkanal symptomer | |
| DE69727691D1 (de) | Verwendung von keratinocyten-wachstumsfaktor-2 | |
| MXPA02006511A (es) | Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido. | |
| EA200701017A1 (ru) | Применение рибозы-цистеина для лечения гипоксии | |
| WO2024112527A3 (en) | Methods for the treatment of thyroid eye disease | |
| SE0200598D0 (sv) | Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences | |
| JP2000178203A5 (https=) | ||
| Cantor et al. | Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25% suspension in patients with elevated intraocular pressure | |
| Ozcan et al. | Symblepharon ring-amniotic membrane application in persistent corneal epithelial defect | |
| EA200300430A1 (ru) | Новые фармацевтические композиции, содержащие эпинастин и псевдоэфедрин |